REJUVENRX

Filed: January 4, 2021
(Based on Intent to Use)(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of cancer, autoimmune…
Owned by: RejuvenRx Inc.
Serial Number: 90446720